StemCyte International, Ltd. (TPE:4178)
18.60
-0.30 (-1.59%)
At close: Jun 2, 2026
StemCyte International Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2013 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '13 Dec 31, 2013 |
Net Income | -179.45 | -176.81 | -205.66 | -319.76 | -54.5 | -60.17 |
Depreciation & Amortization | 62.29 | 62.85 | 63.04 | 57.26 | 57.33 | 26.46 |
Other Amortization | 0.95 | 0.95 | 0.21 | 0.31 | 0.03 | 0.42 |
Loss (Gain) From Sale of Assets | -0.03 | 0.48 | - | - | -75.76 | 0.7 |
Asset Writedown & Restructuring Costs | 5.23 | 5.23 | 1.45 | 95.23 | - | 9.53 |
Loss (Gain) on Equity Investments | - | - | - | - | 0.67 | - |
Stock-Based Compensation | 17.44 | 28.02 | 31.9 | 21.6 | 14.23 | 8.49 |
Provision & Write-off of Bad Debts | 6.16 | 2.21 | 6.22 | 7.23 | 10.49 | - |
Other Operating Activities | 6.61 | 9.76 | -8.14 | 46.63 | -71.11 | -19.67 |
Change in Accounts Receivable | -10.48 | -2.19 | -27.59 | -11.18 | 11.67 | -37.94 |
Change in Inventory | 20.41 | 8.84 | 22.5 | -19.41 | -1.28 | -73.91 |
Change in Accounts Payable | -13.18 | -7.73 | -21.09 | 26.67 | -3.44 | 19.19 |
Change in Unearned Revenue | 1.24 | 9.08 | 3.26 | 9.52 | 22.78 | 48.87 |
Change in Other Net Operating Assets | 4.84 | 6.89 | -7.09 | -6.8 | -7.56 | -206.88 |
Operating Cash Flow | -77.98 | -52.43 | -140.99 | -92.7 | -35.51 | -284.92 |
Capital Expenditures | -1.26 | -2.48 | -30.9 | -5.38 | -5.33 | -31.09 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.52 |
Cash Acquisitions | - | - | - | - | 0.02 | - |
Divestitures | - | - | - | - | -12.03 | - |
Sale (Purchase) of Intangibles | - | - | -0.5 | -0.23 | 0.38 | -3.58 |
Investment in Securities | 356.89 | -90.45 | -177.68 | -88.69 | -56.91 | - |
Other Investing Activities | -8.53 | -15.91 | -8.91 | -11.18 | -9.69 | -0.03 |
Investing Cash Flow | 347.09 | -108.83 | -218 | -105.47 | -83.56 | -34.18 |
Long-Term Debt Issued | - | - | - | 0.5 | - | 150.48 |
Long-Term Debt Repaid | - | -26.85 | -24.87 | -27.74 | -31.12 | -2.93 |
Total Debt Repaid | -27.09 | -26.85 | -24.87 | -27.74 | -31.12 | -2.93 |
Net Debt Issued (Repaid) | -27.09 | -26.85 | -24.87 | -27.24 | -31.12 | 147.55 |
Issuance of Common Stock | 20.92 | 16.77 | 1,199 | 814.71 | 1.03 | - |
Financing Cash Flow | -5.68 | -10.08 | 1,174 | 787.47 | -30.08 | 147.55 |
Foreign Exchange Rate Adjustments | -58.74 | -74.62 | 103.91 | -33.46 | 49.56 | 26.87 |
Net Cash Flow | 204.69 | -245.96 | 919.3 | 555.84 | -99.6 | -144.68 |
Free Cash Flow | -79.24 | -54.9 | -171.89 | -98.08 | -40.85 | -316.01 |
Free Cash Flow Margin | -22.15% | -14.88% | -44.92% | -27.04% | -11.75% | -36.87% |
Free Cash Flow Per Share | -0.41 | -0.29 | -0.95 | -0.68 | -0.29 | -4.06 |
Cash Interest Paid | 12.83 | 13.32 | 10.98 | 2.38 | 2.95 | 1.52 |
Cash Income Tax Paid | 0.44 | 0.6 | 2.29 | 1.85 | - | - |
Levered Free Cash Flow | - | -13.13 | -124.41 | -18.79 | - | -162.67 |
Unlevered Free Cash Flow | - | -4.92 | -117.65 | -17.6 | - | -161.72 |
Change in Working Capital | 2.83 | 14.89 | -30.02 | -1.2 | 22.17 | -250.67 |